RYBELSUS 7 MG COM OR CT BL AL AL X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1176600370064
  • GGREM 526620120009507
  • Código de barras 7897705202715

O que a fonte publica

Detentor do registro
NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
Princípios ativos
SEMAGLUTIDA
Embalagem
7 MG COM OR CT BL AL AL X 30
Tipo de produto
Biológico
Classe terapêutica
A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:526620120009507
{
  "name": "RYBELSUS 7 MG COM OR CT BL AL AL X 30",
  "holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "7897705202715"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526620120009507",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "82.277.955/0001-55",
  "priceRegime": "Regulado",
  "productName": "RYBELSUS",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "7 MG COM OR CT BL AL AL X 30",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "860.83",
    "icms-12": "978.22",
    "icms-17": "1037.14",
    "icms-18": "1049.79",
    "icms-19": "1062.75",
    "icms-20": "1076.04",
    "icms-21": "1089.66",
    "icms-22": "1103.63",
    "icms-23": "1117.96",
    "icms-17.5": "1043.43",
    "icms-19.5": "1069.35",
    "icms-20.5": "1082.81",
    "icms-22.5": "1110.75",
    "icms-12-alc": "873.41",
    "icms-17-alc": "926.02",
    "icms-18-alc": "937.31",
    "icms-19-alc": "948.89",
    "icms-20-alc": "960.75",
    "icms-21-alc": "972.91",
    "icms-22-alc": "985.38",
    "icms-23-alc": "998.18",
    "withoutTaxes": "768.60",
    "icms-17.5-alc": "931.63",
    "icms-19.5-alc": "954.78",
    "icms-20.5-alc": "966.79",
    "icms-22.5-alc": "991.74"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "SEMAGLUTIDA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "1154.77",
    "icms-12": "1312.25",
    "icms-17": "1391.29",
    "icms-18": "1408.26",
    "icms-19": "1425.64",
    "icms-20": "1443.47",
    "icms-21": "1461.74",
    "icms-22": "1480.48",
    "icms-23": "1499.70",
    "icms-17.5": "1399.72",
    "icms-19.5": "1434.49",
    "icms-20.5": "1452.55",
    "icms-22.5": "1490.03",
    "icms-12-alc": "1207.44",
    "icms-17-alc": "1280.17",
    "icms-18-alc": "1295.78",
    "icms-19-alc": "1311.78",
    "icms-20-alc": "1328.18",
    "icms-21-alc": "1344.99",
    "icms-22-alc": "1362.23",
    "icms-23-alc": "1379.93",
    "withoutTaxes": "1062.54",
    "icms-17.5-alc": "1287.92",
    "icms-19.5-alc": "1319.93",
    "icms-20.5-alc": "1336.53",
    "icms-22.5-alc": "1371.02"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "SEMAGLUTIDA"
  ],
  "therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1176600370064",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A10S",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526620120009507"